Phase 0 clinical chemoprevention trial of the Akt inhibitor SR13668
Akt 抑制剂 SR13668 的 0 期临床化学预防试验
期刊:Cancer Prevention Research
影响因子:
doi:10.1158/1940-6207.CAPR-10-0313
Joel M Reid, Chad A Walden, Rui Qin, Katie L Allen Ziegler, John L Haslam, Roger A Rajewski, Roger Warndahl, Cindy L Fitting, Daniel Boring, Eva Szabo, James Crowell, Marjorie Perloff, Ling Jong, Brent A Bauer, Sumithra J Mandrekar, Matthew M Ames, Paul J Limburg; Cancer Prevention Network
